Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

DNA copy number gains in head and neck squamous cell carcinoma

Abstract

Gene amplification, a common mechanism for oncogene activation in cancer, has been used as a tag for the identification of novel oncogenes. DNA amplification is frequently observed in head and neck squamous cell carcinoma (HNSCC) and potential oncogenes have already been reported. We applied restriction landmark genome scanning (RLGS) to study gene amplifications and low-level copy number changes in HNSCC in order to locate previously uncharacterized regions with copy number gains in primary tumor samples. A total of 63 enhanced RLGS fragments, indicative of DNA copy number changes, including gains of single alleles, were scored. Enhanced sequences were identified from 33 different chromosomal regions including those previously reported (e.g. 3q26.3 and 11q13.3) as well as novel regions (e.g. 3q29, 8q13.1, 8q22.3, 9q32, 10q24.32, 14q32.32, 17q25.1 and 20q13.33). Furthermore, our data suggest that amplicons 11q13.3 and 3q26.3–q29 may be divided into possibly two and three independent amplicons, respectively, an observation supported by published microarray expression data.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 4
Figure 3

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Arai H, Ueno T, Tangoku A, Yoshino S, Abe T, Kawauchi S et al. (2003). Cancer Genet Cytogenet 146: 16–21.

  • Bitzer M, Stahl M, Arjumand J, Rees M, Klump B, Heep H et al. (2003). Anticancer Res 23: 1489–1493.

  • Bruch J, Wohr G, Hautmann R, Mattfeldt T, Bruderlein S, Moller P et al. (1998). Genes Chromosomes Cancer 23: 167–174.

  • Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS et al. (2004). Cancer Res 64: 7678–7681.

  • Clancy JL, Henderson MJ, Russell AJ, Anderson DW, Bova RJ, Campbell IG et al. (2003). Oncogene 22: 5070–5081.

  • Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS et al. (1997). Cancer Res 57: 1250–1254.

  • Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F et al. (2004). Oncogene 23: 2484–2498.

  • Curtis LJ, Li Y, Gerbault-Seureau M, Kuick R, Dutrillaux AM, Goubin G et al. (1998). Genomics 53: 42–55.

  • Dai Z, Zhu WG, Morrison CD, Brena RM, Smiraglia DJ, Raval A et al. (2003). Hum Mol Genet 12: 791–801.

  • Du Plessis L, Dietzsch E, Van Gele M, Van Roy N, Van Helden P, Parker MI et al. (1999). Cancer Res 59: 1877–1883.

  • Estilo CL, Charoenrat PO, Ngai I, Patel SG, Reddy PG, Dao S et al. (2003). Clin Cancer Res 9: 2300–2306.

  • Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW et al. (2000). Hum Pathol 31: 169–178.

  • Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, Lam WL . (2004). Genes, Chromosomes Cancer 39: 93–98.

  • Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE et al. (2004). Cancer Res 64: 55–63.

  • Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB . (1996). Proc Natl Acad Sci USA 93: 9821–9826.

  • Hermsen M, Guervos MA, Meijer G, Baak J, van Diest P, Marcos CA et al. (2001). J Pathol 194: 177–182.

  • Hirotsune S, Hatada I, Komatsubara H, Nagai H, Kuma K, Kobayakawa K et al. (1992). Cancer Res 52: 3642–3647.

  • Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M et al. (2002). Genes Chromosomes Cancer 34: 224–233.

  • Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP . (2003). Nucleic Acids Res 31: e15.

  • Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O et al. (1998). Am J Pathol 152: 1107–1123.

  • Komiyama T, Matsumura K, Tsuchida N . (1997). Jpn J Cancer Res 88: 476–483.

  • Larramendy ML, Lushnikova T, Bjorkqvist AM, Wistuba II AK, Shivapurkar N, Gazdar AF et al. (2000). Cancer Genet Cytogenet 119: 132–138.

  • Lukasova E, Kozubek S, Falk M, Kozubek M, Zaloudik J, Vagunda V et al. (2004). Chromosoma 112: 221–230.

  • Lyons SK, Clarke AR . (1997). Br Med Bull 53: 554–569.

  • Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J et al. (2000). Oncogene 19: 2739–2744.

  • Matsumura K, Iritani A, Enomoto S, Torikata C, Matsuyama S, Kurita A et al. (2000). Genes Chromosomes Cancer 29: 207–212.

  • Neve RM, Lane HA, Hynes NE . (2001). Ann Oncol 12 (Suppl 1): S9–S13.

  • Oga A, Kong G, Tae K, Lee Y, Sasaki K . (2001). Cancer Genet Cytogenet 127: 24–29.

  • Pimkhaokham A, Shimada Y, Fukuda Y, Kurihara N, Imoto I, Yang ZQ et al. (2000). Jpn J Cancer Res 91: 1126–1133.

  • Racz A, Brass N, Heckel D, Pahl S, Remberger K, Meese E . (1999). Eur J Cancer 35: 641–646.

  • Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, Zhang FF et al. (2004). BMC Cancer 4: 5.

  • Redon R, Hussenet T, Bour G, Caulee K, Jost B, Muller D et al. (2002). Cancer Res 62: 6211–6217.

  • Riazimand SH, Welkoborsky HJ, Bernauer HS, Jacob R, Mann WJ . (2002). Oncology 63: 385–392.

  • Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suarez C . (2000). Clin Cancer Res 6: 3177–3182.

  • Schimke RT . (1990). Cancer Cells 2: 149–151.

  • Schwab M . (1999). Semin Cancer Biol 9: 319–325.

  • Schwab M, Amler LC . (1990). Genes Chromosomes Cancer 1: 181–193.

  • Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK . (2004). Cancer Res 64: 622–630.

  • Singh B, Gogineni SK, Sacks PG, Shaha AR, Shah JP, Stoffel A et al. (2001). Cancer Res 61: 4506–4513.

  • Smiraglia DJ, Fruhwald MC, Costello JF, McCormick SP, Dai Z, Peltomaki P et al. (1999). Genomics 58: 254–262.

  • Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC . (1995). Cancer Res 55: 1010–1013.

  • Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL et al. (2002). Am J Clin Pathol 117: 791–796.

  • Tang TC, Sham JS, Xie D, Fang Y, Huo KK, Wu QL et al. (2002). Cancer Res 62: 7157–7161.

  • Thoraval D, Asakawa J, Wimmer K, Kuick R, Lamb B, Richardson B et al. (1996). Genes Chromosomes Cancer 17: 234–244.

  • Wu R, Lin L, Beer DG, Ellenson LH, Lamb BJ, Rouillard JM et al. (2003). Am J Pathol 162: 1603–1610.

Download references

Acknowledgements

We thank Kristi Bennett for her critical revisions and discussions of the manuscript. This work was supported in part by a grant from NIDCR, DE13123-02 (CP).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Plass.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, M., Smith, L., Smiraglia, D. et al. DNA copy number gains in head and neck squamous cell carcinoma. Oncogene 25, 1424–1433 (2006). https://doi.org/10.1038/sj.onc.1209166

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209166

Keywords

This article is cited by

Search

Quick links